How many years can you live after laryngeal cancer surgery

Cancer is a systemic disease. Surgery is a local excision. The peak period of recurrence and spread is 1-3 years after surgery, so many people think that the survival period after surgery is only a few years, or even less. That is because the treatment after surgery is improper. There are many factors that affect the survival of laryngeal cancer, so the specific survival period cannot be evaluated. Generally, under the condition of proper postoperative conditioning in the early stage, the 5-year survival rate can reach about 90%. The prognosis of the middle and late stages will be relatively poor. You should pay more attention to healthy diet, avoid smoking and drinking, and try to avoid smoking occasions to reduce the inhalation of secondhand smoke. In addition, you can also take Chinese medicine to assist in treatment. Many medicines can significantly improve the effect, and at the same time have no obvious blood system toxicity, and improve the quality of life. Whether the disease can be treated depends on many factors. For example, the time when the cancer is discovered, the size, the scope of invasion, whether there is distant metastasis, and the degree of differentiation of the tumor and the patient's own physical constitution and other factors determine it. Treatment also needs to choose surgery or radiotherapy and chemotherapy according to different situations. So the prognosis of this disease is also different. If some cancers are found in the early stage and have a high degree of differentiation, the prognosis of early treatment is still good, but if it reaches the middle and late stages, the prognosis is very poor and there is basically no possibility of cure. At present, the main treatments for laryngeal cancer include surgery, radiotherapy, chemotherapy, biological therapy, etc. Among them, surgery is the main and most effective treatment method.

Surgical treatment: Different laryngeal cancers require different surgical treatments. Laryngeal carcinoma in situ is suitable for endoscopic resection; glottic cancer is suitable for partial laryngectomy; supraglottic cancer is suitable for supraglottic laryngectomy; and total laryngectomy is suitable for total laryngeal cancer. At present, these surgeries are characterized by minimally invasive, preservation of vocal function, less bleeding, and full diffusion. Combination of surgery and radiotherapy: refers to surgery plus preoperative or postoperative radiotherapy, which can increase the 5-year survival rate of surgical treatment by 10-20%. Biological therapy: Although there are some reports, most biological treatments are in the experimental stage and the efficacy is not confirmed. Including recombinant cytokines, adoptively transferred immune cells, monoclonal antibodies, tumor molecular vaccines, etc.